ALPS Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,659
Closed -$344K 1067
2023
Q2
$344K Buy
1,659
+12
+0.7% +$2.33K ﹤0.01% 748
2023
Q1
$325K Buy
1,647
+41
+3% +$8.44K ﹤0.01% 779
2022
Q4
$325K Sell
1,606
-12
-0.7% -$2.35K ﹤0.01% 807
2022
Q3
$285K Buy
1,618
+130
+9% +$26.6K ﹤0.01% 885
2022
Q2
$300K Sell
1,488
-15
-1% -$3.2K ﹤0.01% 809
2022
Q1
$340K Buy
1,503
+60
+4% +$14.1K ﹤0.01% 693
2021
Q4
$390K Buy
1,443
+18
+1% +$4.46K ﹤0.01% 691
2021
Q3
$344K Sell
1,425
-228
-14% -$57.5K ﹤0.01% 767
2021
Q2
$392K Hold
1,653
﹤0.01% 586
2021
Q1
$362K Buy
+1,653
New +$332K ﹤0.01% 542
2020
Q3
Sell
-1,894
Closed -$270K 890
2020
Q2
$270K Sell
1,894
-209
-10% -$28.9K ﹤0.01% 598
2020
Q1
$228K Buy
+2,103
New +$303K ﹤0.01% 667
2019
Q1
Sell
-3,849
Closed -$418K 954
2018
Q4
$418K Buy
3,849
+10
+0.3% +$1.34K ﹤0.01% 559
2018
Q3
$573K Buy
3,839
+281
+8% +$42.7K ﹤0.01% 524
2018
Q2
$549K Buy
3,558
+355
+11% +$53.6K ﹤0.01% 524
2018
Q1
$445K Buy
+3,203
New +$470K ﹤0.01% 735

Other funds holding LH

ALPS Advisors's LH Position: Q3 2023 in Review

ALPS Advisors sold out of Labcorp (LH) in Q3 2023, closing a stake of 1,659 shares — an estimated $344K sold.

ALPS Advisors first reported a position in LH in Q1 2018 and held it in 16 quarters. The position peaked at $573K in Q3 2018. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

  • ALPS Advisors reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
  • ALPS Advisors sold 1,659 Labcorp shares in Q3 2023, an estimated $344K.
  • ALPS Advisors first reported a position in Labcorp in Q1 2018 and held it in 16 quarters.
  • ALPS Advisors's Labcorp position peaked at $573K in Q3 2018.
  • 881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on ALPS Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.